Part 2/7:
Icahn's announcement was marked by a certain ambiguity regarding the scale of his investment. While he described his stake as "large," specifics were scant. Industry observers, including Todd Campbell, raised questions about whether this means a substantial amount relative to its context or merely in the eyes of Icahn himself. However, the significant aspect remains: Icahn has made a foray into Allergan and vocalized his confidence in Brent Saunders, the company’s CEO.